General Information of the Compound
Compound ID
CP0135911
Compound Name
4-(2-(1H-indol-6-yl)-9H-purin-6-yl)morpholine
    Show/Hide
Synonyms
4-(2-(1H-indol-6-yl)-9H-purin-6-yl)morpholine
CHEMBL611630
    Show/Hide
Structure
Formula
C17H16N6O
Molecular Weight
320.356
Canonical SMILES
C1CN(CCO1)c1nc(nc2nc[nH]c12)-c1ccc2cc[nH]c2c1
    Show/Hide
InChI
InChI=1S/C17H16N6O/c1-2-12(9-13-11(1)3-4-18-13)15-21-16-14(19-10-20-16)17(22-15)23-5-7-24-8-6-23/h1-4,9-10,18H,5-8H2,(H,19,20,21,22)
    Show/Hide
InChIKey
LYJKHCYTQHFQLX-UHFFFAOYSA-N
Physicochemical Property
logP
2.3378
Rotatable Bonds
2
Heavy Atom Count
24
Polar Areas
82.72
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 46225260
ChEMBL ID
CHEMBL611630
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 150 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 4-(2-(1H-indol-6-yl)-9H-purin-6-yl)morpholine )
Drug Name 4-(2-(1H-indol-6-yl)-9H-purin-6-yl)morpholine
Target(s)
Serine/threonine-protein kinase mTOR (mTOR)
Inhibitor